The latest price target for GeneDx Holdings (NASDAQ:WGS) was reported by Wells Fargo on December 15, 2025. The analyst firm set a price target for $155.00 expecting WGS to rise to within 12 months (a possible 2.91% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for GeneDx Holdings (NASDAQ:WGS) was provided by Wells Fargo, and GeneDx Holdings maintained their equal-weight rating.

The last upgrade for GeneDx Holdings Corp happened on May 9, 2025 when Jefferies raised their price target to $80. Jefferies previously had a hold for GeneDx Holdings Corp.

There is no last downgrade for GeneDx Holdings.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GeneDx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GeneDx Holdings was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.

While ratings are subjective and will change, the latest GeneDx Holdings (WGS) rating was a maintained with a price target of $140.00 to $155.00. The current price GeneDx Holdings (WGS) is trading at is $150.61, which is within the analyst’s predicted range.